Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Aurelio Matamoros Image

      Aurelio Matamoros, M.D.

      Department of Abdominal Imaging, Division of Diagnostic Imaging

      About Dr. Aurelio Matamoros

      Aurelio Matamoros Jr., MD is a Professor of Radiology at the University of Texas MD Anderson Cancer Center.  He received his Bachelor's Degree in Biological Sciences from the University of Texas, El Paso, his Medical Degree from the University of Colorado Health Science Center and completed his residency in Diagnostic Imaging at David Grant Medical Center, Travis Air Force Base, California, followed by a fellowship in Abdominal Imaging at the University of Nebraska Medical Center.  Following fellowship, Dr. Matamoros was a staff radiologist at the University of Nebraska for 13 years with primary interest in abdominal imaging, organ transplantation and trauma.  For the past 16+ years, Dr. Matamoros has been a staff radiologist at MD Anderson Cancer Center specializing in abdominal imaging. His career has been dedicated to academic medicine, medical students, residents, fellows and mid-level providers. He has presented at numerous professional meetings and has authored or co-authored abstracts, articles, book chapters and exhibits.  Dr. Matamoros is a member of the Harris County Emergency Care Committee, Texas Medical Association, Texas Medical Association CME Committee, MOC committees and multiple administrative committees at MD Anderson Cancer Center. His primary interests are imaging and clinical correlation.  He is a collaborator on numerous protocols and a reviewer for the Journals of Gastroenterology, Society of Nuclear Medicine and Molecular Imaging and he has recently joined the Editorial Board of Current Imaging Reviews. 
      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Research Interests

      Multi-modality molecular imaging in cancer research

      Education & Training

      Degree-Granting Education

      1978University of Colorado, Denver, Colorado, US, MD
      1974Incarnate Word College, San Antonio, Texas, US, Nursing, BS
      1967The University of Texas, El Paso, Texas, US, Biological Sciences, BS

      Postgraduate Training

      1988-1989Clinical Fellowship, Body Imaging, University of Nebraska Medical Center Department of Radiology, Omaha, Nebraska
      1983-1986Residency, Diagnostic Radiology, David Grant Medical Center Department of Radiology, Travis Air Force Base, California
      1978-1979Internship, PG-1, General Surgery, David Grant Medical Center Department of General Surgery, Travis Air Force Base, California

      Licenses & Certifications

      2014The American Board of Medical Quality
      1988Nebraska Medical Board
      1987American Board of Radiology
      1980Texas Medical Board

      Experience & Service

      Faculty Academic Appointments

      Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, School of Health Professions, Houston, TX, 2007 - 2019

      Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2019

      Associate Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2000 - 2004

      Associate Professor, Diagnostic Radiology, University of Nebraska Medical Center, Omaha, NE, 1996 - 2000

      Instructor, University of Nebraska Medical Center, Omaha, NE, 1989 - 1998

      Administrative Appointments/Responsibilities

      Executive Medical Advisor, The University of Texas MD Anderson School of Health Professions, 2017 - Present

      Section Chief ad interim, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2016

      Director of Clinical Ultrasound, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2003

      Vice Chairman, Diagnostic Radiology, University of Nebraska Medical Center, Omaha, NE, 1999 - 2000

      Chairman, Department of Primary Care, David Grant Medical Center, Travis Air Force Base, CA, 1982 - 1983

      Chief, Emergency Room, United States Air Force, Hickman Air Force Base, HI, 1979 - 1982

      Other Professional Positions

      Department of Abdominal Imaging Representative for the Credentials Committee of the Medical Staff Office, MD Anderson Cancer Center, Houston, TX, 2019 - Present

      Executive Advisor, The University of Texas MD Anderson School of Health Professions, Houston, TX, 2007 - Present

      Member, Diversity Training Committee, University of Nebraska Medical Center School of Medicine, Omaha, NE, 1998 - 1999

      Chairman, Physician's Compensation Committee, University of Nebraska Medical Center, Radiology Department, Omaha, NE, 1997 - 2000

      Chairman, Manpower Committee, University of Nebraska Medical Center Radiology Department, Omaha, NE, 1997 - 2000

      Member, Department of Radiology Systems Redesign Committee, University of Nebraska Medical Center School of Medicine, Omaha, NE, 1996 - 1998

      Member, NHS Performance Improvement Committee, University of Nebraska Medical Center School of Medicine, Omaha, NE, 1996 - 1997

      Member, Admissions Committee, University of Nebraska Medical Center School of Medicine, Omaha, NE, 1995 - 1999

      Member, NHS Conscious Sedation Committee, University of Nebraska Medical Center School of Medicine, Omaha, NE, 1995 - 1996

      Member, Pancreatic Transplant Committee, University of Nebraska Medical Center School of Medicine, Omaha, NE, 1992 - 1999

      Member, Pharmacy and Therapeutics Hospital Committee, University of Nebraska Medical Center School of Medicine, Omaha, NE, 1991 - 1995

      Retired Colonel United States Air Force, United States Air Force, 1967 - 1988

      Intramural Institutional Committee Activities

      Member, GI Radiation Oncology Chair Search, The University of Texas MD Anderson Cancer Center, 2026 - Present

      Extramural Institutional Committee Activities

      Member, Senior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Member, School of Health Professions RFA Progress Review Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Member, Professional Education Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Member, Continuing Education Commitee, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Member, Strategic Planning Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2016

      Officer, Faculty Emergency Preparedness Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2016

      Member, Faculty Merit Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2016

      Member, Diagnostic Imaging Education Functional Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Member, Perioperative Safety Council, The University of Texas MD Anderson Cancer Center, 2013 - 2020

      Member, The University of Texas MD Anderson School of Health Professions Appointment and Promotion Committee, The University of Texas MD Anderson Cancer Center, 2011 - Present

      Member, The University of Texas Body Imaging QI Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2011

      Editorial Activities

      Regional Editor, Current Medical Imaging Reviews, 2014 - 2016

      Honors & Awards

      2013Certificate of Merit, Radiological Society of North America
      1999The Pancreatic Cancer Think Tank, National Cancer Institute
      1991Certificate of Merit, American Roentgen Ray Society
      1970Bronze Star, Vietnam War

      Professional Memberships

      Society of Hematologic Oncology

      2021 - Present

      Association for the Advancement of Artificial Intelligence

      2017 - 2018

      Southern Medical Association on Quality

      2013 - 2015

      Society of Nuclear Medicine and Molecular Imaging

      2010 - Present

      Harris County Medical Society

      2010 - Present

      The University of Texas MD Anderson School of Health Professions

      2007 - Present

      Texas Medical Association

      2000 - Present

      Harris County Medical Society

      2000 - 2015

      The American Institute of Ultrasound in Medicine

      1997

      American Roentgen Ray Society

      1990 - 2012

      Nebraska Radiological Society

      1988 - 2000

      Selected Presentations & Talks

      Regional Presentations

      1. 1996. Intraoperative sonography. Conference. Nebraska State Ultrasound Society. Omaha, NE, US.
      2. 1996. Intraoperative sonography. Conference. Greater Kansas City Ultrasound Society Meeting. Kansas City, KS, US.

      National Presentations

      1. 2024. Utility of gene expression-based cancer classification in diagnosis of malignant peritoneal mesothelioma: Filling the gaps in standard pathologic work-up for a rare cancer. Conference. American Society of Clinical Oncology GI Symposium. San Francisco, CA, US.
      2. 2023. MorphoSys’ phase 3 study of pelabresib in myelofibrosis demonstrates statistically significant improvement in spleen volume reduction and strong positive trend in symptom reduction. Conference. American Society of Hematology Annual Meeting. San Diego, CA, US.
      3. 2021. Malignant Peritoneal Mesothelioma. Conference. American Society of Clinical Oncology Annual Meeting, US.
      4. 2013. Imaging and Staging of Rectal Cancer. Invited. Southern Medical Society Annual Scientific Assembly. Destin, FL, US.
      5. 2001. Renal sonography. Invited. American Urologic Association Annual Meeting. Houston, TX, US.
      6. 1999. Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: A phase II trial using intermittent percutaneous Hepatic arterial access. Conference. American Society of Clinical Oncology Annual Meeting. Atlanta, GA, US.
      7. 1999. A new percutaneous technique for the Induction of surrogate tolerogenesis in a pig and sheep xenograft model. Conference. Annual Meeting of the Society of Cardiovascular and Interventional Radiology. Orlando, FL, US.
      8. 1997. Ultrasound. Invited. Advanced Abdominal Medical Symposium. Kansas City, KS, US.
      9. 1997. A comparison of transcutaneous ultrasonography and radioscintigraphy in the assessment of gastric emptying in patients with portal hypertension. Conference. American Gastroenterological Association and American Association for the Study of Liver Diseases Annual Meeting. Washington, DC, US.
      10. 1997. Correlation of azygos blood flow and diameter as determined by endoscopic ultrasound with color doppler and endoscopic features of portal hypertension. Conference. American Gastroenterological Association and American Association for the Study of Liver Diseases Annual Meeting. Washington, DC, US.
      11. 1997. Computer assisted dynamic color doppler ultrasound study for erectile dysfunction. Conference. American Urological Association Annual Meeting. New Orleans, LA, US.
      12. 1997. Assessment of diagnostic criteria and development of a score system for color doppler ultrasound diagnosis of variococele. Conference. American Urological Association Annual Meeting. New Orleans, LA, US.
      13. 1997. Urethral sonography for stricture: current experience and the role of color doppler imaging. Conference. American Urological Association Annual Meeting. New Orleans, LA, US.
      14. 1997. Growth of ultrasound fetal weight in prediction of intrauterine growth retardation. Conference. American Institute of Ultrasound in Medicine Convention. San Diego, CA, US.
      15. 1997. Assessment of color doppler ultrasound diagnostic criteria for varicocele. Conference. American Institute of Ultrasound in Medicine Convention. San Diego, CA, US.
      16. 1997. Hemodynamic evaluation of erectile dysfunction and Peryronie's disease using color doppler. Conference. American Institute of Ultrasound in Medicine Convention. San Diego, CA, US.
      17. 1997. Urethral sonography: current experience and the role of color doppler imaging. Conference. American Institute of Ultrasound in Medicine Convention. San Diego, CA, US.
      18. 1996. The determination of azygos venous blood flow by endoscopic ultrasound with color doppler. Conference. American Gastroenterological Association and American Association for the Study of Liver Diseases. San Francisco, CA, US.
      19. 1996. The determination of azygous venous blood flow by endoscopic ultrasound with color doppler. Conference. Astra-Merck Young Investigators Conference in Diagnostic Diseases. Coeur d'Alene, ID, US.
      20. 1996. Imaging of hepatic cryoablation. Invited. Cryosurgical Conference. Minneapolis, MN, US.
      21. 1995. Videoscopic retroperitoneal aortic ligation. Conference. Endo Expo Society of Laparoendoscopic Surgeons Annual Meeting. Orlando, FL, US.
      22. 1995. Color doppler ultrasound diagnosis of varicocele and correlation with physical examination. Conference. South Central Section. Kansas City, MO, US.
      23. 1995. Experience with protocol biopsies after solitary pancreas transplantation. Conference. Annual Meeting of the American Society of Transplant Physicians. Chicago, IL, US.
      24. 1995. Imaging in hepatobiliary trauma, in-depth review: hepatobiliary surgery update. Invited. American College of Osteopathic Surgeons. Snowmass, CO, US.
      25. 1995. Imaging techniques: the diagnosis of primary and metastatic liver malignancies. Invited. American College of Osteopathic Surgeons. Snowmass, CO, US.
      26. 1995. Color doppler ultrasound diagnosis of varicocele and correlation with physical examination. Conference. American Urologic Association Annual Meeting. Las Vegas, NV, US.
      27. 1995. The radiologist's perspective: imaging for hepatic resection-preoperative and intraoperative evaluation. Invited. American College of Osteopathic Surgeons. Snowmass, CO, US.
      28. 1994. Sonography of the musculoskeletal system. Conference. Annual Post-Graduate Assembly. Omaha, NE, US.
      29. 1994. Imaging of ovarian cancer prior to second look laparotomy. Conference. Society of Nuclear Medicine Annual Meeting. Orlando, FL, US.
      30. 1994. Orthotopic auxiliary grafts: radiographic findings. Conference. American Roentgen Ray Society Annual Meeting. New Orleans, LA, US.
      31. 1992. Amniotic fluid index of twins compared with singleton pregnancies. Conference. American Institute of Ultrasound in Medicine Annual Meeting. San Diego, CA, US.
      32. 1991. Transvaginal sonography of the cervix: normal anatomy and prediction of pre-term delivery. Conference. American Institute of Ultrasound in Medicine Annual Meeting. Atlanta, GA, US.
      33. 1989. Shock wave lithotripsy. Conference. Annual Symposium on Shock Wave Lithotripsy. Indianapolis, IN, US.

      International Presentations

      1. 2022. Neoadjuvant chemotherapy in malignant peritoneal mesothelioma treated with cytoreduction and heated intraperitoneal chemotherapy. Conference. Congress of the European Society of Surgical Oncology, FR.
      2. 2007. Positron Emission Tomography in Colorectal Cancer. Invited. Course on Colorectal Cancer. Quito, EC.
      3. 2007. Computed Tomography Colonography. Invited. Course on Colorectal Cancer. Quito, EC.
      4. 1996. Laparoscopic radiofrequency ablation of kidney: experimental study. Invited. World Congress of Endourology. Victoria, AU.
      5. 1996. Endourology. Invited. World Congress of Endourology. Victoria, AU.
      6. 1993. Preoperative evaluation of donor liver volume in pediatric living related liver transplantation: how accurate is it?. Conference. Congress of the European Society for Organ Transplantation. Rodos, GR.
      7. 1993. Preoperative evaluation of donor liver volume in pediatric living related liver transplantation: how accurate is it?. Conference. First International Congress on Pediatric Transplantation. Minneapolis, US.

      Formal Peers

      1. 1999. Prevention of hyperacute rejection of pig xenografts by surrogate tolerogenesis. Invited. Lincoln, NE, US.
      2. 1997. Penile hemodynamic evaluation for erectile dysfunction using color doppler ultrasound. Invited. Omaha, NE, US.
      3. 1996. Hepatic mesenchymal hamartomas. Invited. Omaha, NE, US.
      4. 1996. Intraoperative sonography. Invited. Augusta, GA, US.
      5. 1996. Endoscopic ultrasound. Invited. Omaha, NE, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2008 - 2010
      Title:Targeting Inducible Radioresistance Using Curcumin in Rectal Cancer
      Funding Source:Cancer Treatment Research Foundation
      Role:Collaborator
      ID:P-07-010 01
      Title:Cardiac Xenotransplantation Using Surrogate Tolerogenesis
      Funding Source:
      Role:Investigators, Benschomer, W. E., Matamoros, A., Goertzen, T., McGowan, T., et al
      Title:Image-guided detection of tumor margins using fluorescence imaging and high-resolution microendoscopy to permit conservative management of endometrial cancer
      Funding Source:Cancer Prevention Research Institute of Texas
      Role:Co-I
      Title:The WAND Anesthetic Delivery System vs. Traditional Handheld Syringes: A Pilot CT Scan Study of the Spread of the Solution for PDL Anesthesia
      Funding Source:
      Role:Investigator
      Title:Imaging of Human Pancreatic Cancer in a Syrian Hamster Model Using Ultrasound and MRI, Supplement to SPORE: Spore in Gastrointestinal Cancer
      Funding Source:NCI
      Role:Investigator

      Selected Publications

      Peer-Reviewed Articles

      1. Shen JP, Yousef AM, Zeineddine FA, Zeineddine MA, Tidwell RS, Beaty KA, Scofield LC, Rafeeq S, Hornstein N, Lano E, Eng C, Matamoros A, Foo WC, Uppal A, Scally C, Mansfield P, Taggart M, Raghav KP, Overman MJ, Fournier K. Efficacy of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma: A randomized crossover trial. JAMA Netw Open 1(6):e2316161, 2024. e-Pub 2024. PMID: 37261831.
      2. Allam, J, Ma, L, Estrella, JS, Willett, A, Beaty, K, Matamoros Jr, A, Lano, EA, Fournier, KF, Treuner, K, Raghav, KS, Huey, RW. Utility of gene expression–based cancer classification in diagnosis of malignant peritoneal mesothelioma (MPeM). Journal of Clinical Oncology 42(3), 2024. e-Pub 2024.
      3. Bhutiani N, Grotz TE, Concors SJ, White MG, Helmink BA, Raghav KP, Taggart MW, Beaty KA, Royal RE, Overman MJ, Matamoros A, Scally CP, Rafeeq S, Mansfield PF, Fournier KF. Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent mucinous appendiceal adenocarcinoma: A viable treatment strategy with demonstrable benefit. Ann Surg Oncol 31(1):614-621, 2024. e-Pub 2024. PMID: 37872456.
      4. Huey RW, Shah AT, Reddi HV, Dasari P, Topham JT, Hwang H, Dhillon N, Willett A, Smaglo BG, Estrella JS, Rashid A, Matamoros A, Overman MJ, Choquette L, Omerza G, Kelly K, Wang X, Loree JM, Rueter J, Varadhachary GR, Raghav K. Feasibility and value of genomic-profiling in cancer of unknown primary: real-world evidence from prospective profiling study. J Natl Cancer Inst 115(8):994-997, 2023. e-Pub 2023. PMID: 37202363.
      5. Vassilakopoulou M, Chen HC, Wang X, Harada K, Iwatsuki M, Das P, Blum Murphy M, Matamoros A, Sagebiel T, Devine C, Thomas I, Sanders EM, Shanbhag N, Rogers JE, Lee JH, Weston B, Bhutani MS, Hofstetter W, Nguyen QN, Badgwell BD, Ajani JA. Localized gastroesophageal adenocarcinoma in the elderly: is age a factor associated with suboptimal treatment?. Oncology 101(23):153-158, 2022. e-Pub 2022. PMID: 36412619.
      6. Huey RW, Smaglo BG, Estrella JS, Matamoros A, Overman MJ, Varadhachary GR, Raghav KPS. Cancer of unknown primary presenting as bone-predominant or lymph node-only disease: a clinicopathologic portrait. Oncologist 26(4):e650-e657, 2021. e-Pub 2021. PMID: 33524217.
      7. Raghav K, Hwang H, Jácome AA, Bhang E, Willett A, Huey RW, Dhillon NP, Modha J, Smaglo BG, Matamoros A, Estrella JS, Jao J, Overman MJ, Wang X, Greco FA, Loree JM, Varadhachary GR. Development and validation of a novel nomogram for individualized prediction of survival in cancer of unknown primary. Clin Cancer Res 27(12):3414-3421, 2021. e-Pub 2021. PMID: 33858857.
      8. Raghav K, Shen JP, Jácome AA, Guerra JL, Scally CP, Taggart MW, Foo WC, Matamoros A, Shaw KR, Fournier K, Overman MJ, Eng C. Integrated clinicomolecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer. Br J Cancer 123(8):1262-1270, 2020. e-Pub 2020. PMID: 32733093.
      9. Huey RW, Makawita S, Xiao L, Matamoros A, Estrella JS, Overman MJ, Varadhachary GR, Raghav K. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait. BMC Cancer 19(1):965, 2019. e-Pub 2019. PMID: 31623602.
      10. Bose P, Swaminathan M, Pemmaraju N, Ferrajoli A, Jabbour EJ, Daver NG, DiNardo CD, Alvarado Y, Yilmaz M, Huynh-Lu J, Qiao W, Wang X, Matamoros A, Zhou L, Pierce S, Schroeder KD, Kantarjian HM, Verstovsek S. A phase 2 study of pracinostat combined with ruxolitinib in patients with myelofibrosis. Leuk Lymphoma 60(7):1767-1774, 2019. e-Pub 2019. PMID: 30632841.
      11. Nogueras G, Harada K, Ghazanfari AF, Roy-Chowduri S, Estrella J, Das P, Lee J, Weston B, Matamoros A, Thomas I, Lin Q, Badgwell B. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma. J Surg Oncol 117(4):678-684, 2018. e-Pub 2018. PMID: 29205363.
      12. Ikoma N, Lee JH, Bhutani MS, Ross WA, Weston B, Chiang YJ, Blum MA, Sagebiel T, Devine CE, Matamoros A, Fournier K, Mansfield P, Ajani JA, Badgwell BD. Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonography. J Gastrointest Oncol 8(6):1009-1017, 2017. e-Pub 2017. PMID: 29299361.
      13. Sagebiel TL, Mohamed A, Matamoros A, Taggart MW, Doamekpor F, Raghac KP, Mann GN, Mansfield PF, Eng C, Royal RE, Foo WC, Ensor JE, Fournier KF, Overman MJ. Utility of appendiceal calcification detected on computed tomography as a predictor for an underlying appendiceal epitheal neoplasm. Ann Surg Oncol 24(12):3667-3672, 2017. e-Pub 2017. PMID: 28831698.
      14. Elimova E, Slack RS, Chen HC, Planjery V, Shiozaki H, Shimodaira Y, Charalampakis N, Lin Q, Harada K, Wadhwa R, Estrella JS, Kaya DM, Sagebiel T, Lee JH, Weston B, Bhutani M, Murphy MB, Matamoros A, Minsky B, Das P, Mansfield PF, Badgwell BD, Ajani JA. Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance. Oncotarget 8(46):81430-81440, 2017. e-Pub 2017. PMID: 29113402.
      15. Edward GT, Royal Richard E, Paul M, James OM, Mann Gary N, Ashlee RK, Beaty Karen A, Safia R, Matamoros A, Taggart Michelle W, Francis FK. Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastesis by histological grade. WJGO 9(9):345-362, 2017. e-Pub 2017. PMID: 28979717.
      16. Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for moderately and poorly differentiated appendiceal adenocarcinoma: Survival outcomes and patient selection. Ann Surg Oncol 24(9):2646-2654, 2017. e-Pub 2017. PMID: 28695394.
      17. Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mares J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Matamoros A, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Co-morbidities rather than age impact outcomes in patients receiving preoperative therapy for gastroesophageal Adenocarcinoma. Ann Surg Oncol 24(8):2291-2301, 2017. e-Pub 2017. PMID: 27770339.
      18. Mizrak Kaya D, Wang X, Harada K, Blum Murphy MA, Das P, Minsky BD, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Matamoros A, Sagebiel T, Wu CC, Rogers JE, Thomas I, Maru DM, Skinner HD, Badgwell BD, Hofstetter WL, Ajani JA. 101 Long-term survivors who had metastatic gastroesophageal cancer and received local consolidative therapy. Oncology 93(4):243-248, 2017. e-Pub 2017. PMID: 28683449.
      19. Al-Shamsi HO, Fahmawi Y, Dahbour I, Tabash A, Rogers JE, Mares JE, Blum MA, Estrella J, Matamoros A, Sagebiel T, Devine CE, Badgwell BD, Lin QD, Das P, Ajani JA. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: The University of Texas MD Anderson experience. J Gastrointest Oncol 7(4):499-505, 2016. e-Pub 2016. PMID: 27563438.
      20. Badgwell B, Ajani J, Blum M, Ho L, Fournier K, Chiang YJ, Matamoros A, Das P, Mansfield P. Postoperative morbidity and mortality rates are not increased for patients with gastric and gastroesophageal cancer who undergo preoperative chemoradiation therapy. Ann Surg Oncol 23(1):156-62, 2016. e-Pub 2016. PMID: 26059652.
      21. Raghav K, Mhadgut H, McQuade JL, Lei X, Ross A, Matamoros A, Wang H, Overman MJ, Varadhachary GR. Cancer of unknown primary in adolescents and young adults: clinicopathological features, prognostic factors and survival outcomes. PLoS One 11(5):e0154985, 2016. e-Pub 2016. PMID: 27171493.
      22. Shiozaki H, Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Matamoros A, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak Kaya D, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JA. Metastatic gastroesophageal adenocarcinoma patients treated with systemic therapy followed by consolidative local therapy: mammogram associated with long-term survivors. Oncology 91(1):55-60, 2016. e-Pub 2016. PMID: 27120436.
      23. Charalampakis N, Nogueras González GM, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Rogers JE, Harada K, Matamoros A, Sagebiel T, Das P, Minsky BD, Lee JH, Weston B, Bhutani MS, Estrella JS, Badgwell BD, Ajani JA. The proportion of signet ring cell component in patients with localized gastric adenocarcinoma correlates with the degree of response to preoperative chemoradiation. Oncology 90(5):239-47, 2016. e-Pub 2016. PMID: 27046280.
      24. Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Matamoros A, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial standardized uptake value of positron emission tomography influences the prognosis of patients with localized gastric adenocarcinoma treated preoperatively. Oncology 89(6):305-310, 2015. e-Pub 2015.
      25. Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF. A simplified preoperative assessment predicts complete cytoreduction and outcomes in patients with low-grade mucinous adenocarcinoma of the appendix. Ann Surg Oncol 22(11):3640-6, 2015. e-Pub 2015. PMID: 25698402.
      26. Haygood TM, Sayyouh M, Wong J, Lin JC, Matamoros A, Sandler C, Madewell JE. Skeletal muscle metastasis from renal cell carcinoma: 21 cases and review of the literature. Sultan Qaboos Univ Med J 15(3):e327-37, 2015. e-Pub 2015. PMID: 26357552.
      27. Badgwell B, Blum M, Estrella J, Chiang YJ, Das P, Matamoros A, Fournier K, Mansfield P, Ajani J. Predictors of survival in patients with resectable gastric cancer treated with preoperative chemoradiation therapy and gastrectomy. J Am Coll Surg 221(1):83-90, 2015. e-Pub 2015. PMID: 26002780.
      28. Badgwell B, Roy-Chowdhuri S, Chiang YJ, Matamoros A, Blum M, Fournier K, Mansfield P, Ajani J. Long-term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery. J Surg Oncol 111(7):875-81, 2015. e-Pub 2015. PMID: 25872485.
      29. Elimova E, Wadhwa R, Sudo K, Estrella JS, Das P, Matamoros A, Song S, Ajani JA. Molecular biomarkers in gastric cancer. J Natl Compr Canc Netw 4:19-29, 2015. e-Pub 2015. PMID: 26052595.
      30. Overman MJ, Eng C, Raghav K, Matamoros A, Taggart M, Foo WC, Fournier K. Challenges of efficacy assessments in pseudomyxoma peritonea. Oncologist 20(3):e3-4, 2015. e-Pub 2015. PMID: 25745054.
      31. Elimova E, Shiozaki H, Slack RS, Chen HC, Wadhwa R, Sudo K, Charalampakis N, Hiremath A, Estrella JS, Matamoros A, Sagebiel T, Das P, Rogers JE, Garris JL, Blum MA, Badgwell B, Ajani JA. Early versus delayed therapy of advanced gastric cancer patients--does it make a difference?. Oncology 89(4):215-20, 2015. e-Pub 2015. PMID: 26159599.
      32. Haygood TM, Liu MA, Bassett R, Murphy W, Ng C, Matamoros A, Marom E. Consistency of response and image recongnition, pulmonary nodules. Br J Radiol 87(1038), 2014. e-Pub 2014. PMID: 24697724.
      33. Haygood TM, Wong J, Lin JC, Li S, Matamoros A, Costelloe CM, Yeung H, Sandler CM, Nunez RF, Kumar R, Madewell JE. Skeletal muscle metastases: a three-part study of a not-so-rare entity. Skeletal Radiol 41(8):899-909, 2012. e-Pub 2012. PMID: 22101865.
      34. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradiation without surgery: The University of Texas MD Anderson Cancer Center experience. Oncology 82(6):347-51, 2012. e-Pub 2012. PMID: 22677933.
      35. Varadhachary GR, Raber MN, Matamoros A, Abbruzzese JL. Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions. Lancet Oncol 9(6):596-599, 2008. e-Pub 2008. PMID: 18510991.
      36. Beschorner WE, Sudan DL, Radio SJ, Yang T, Franco KL, Hill AC, Shearon CC, Thompson SC, Dixon RS, Johnson ND, Kuszynski CA, Rubocki RJ, Lechtenberg KF, Matamoros A, Goertzen TC, Fox IJ, Langnas AN. Heart xenograft survival with chimeric pig donors and modest immune suppression. Ann Surg 237(2):265-272, 2003. e-Pub 2003. PMID: 12560785.
      37. Beschorner W, Sudan D, Yang T, Radio S, Stammers A, Johnson N, Shearon C, Kuszynski C, Dixon RS, Matamoros A, Langnas A. Surrogate tolerogenesis: possible pretransplant induction of accommodation of pig xenografts. Transplant Proc 32(5):994-995, 2000. e-Pub 2000. PMID: 10936317.
      38. Matamoros A. A teardrop may not be resectable. Am J Gastroenterol 95(4):865, 2000. e-Pub 2000. PMID: 10763926.
      39. Sudan DL, Radio SJ, Matamoros A, Johnson ND, Shearon CC, Glogowski KR, Hill AC, Goertzen TC, Fox IJ, Langnas AN, Beschorner WE. Effect of surrogate tolerogenesis on the vascular rejection of pig heart xenografts. Transplantation 69(2):232-235, 2000. e-Pub 2000. PMID: 10670632.
      40. Matamoros A. Looks broken. needs fixing?. Am J Gastroenterol 94(12):3404, 1999. e-Pub 1999. PMID: 10606291.
      41. Remmler D, Olson L, Ekstrom R, Duke D, Matamoros A, Matthews D, Ullrich CG. Pre-surgical computed tomography/FEA for craniofacial distraction: methodology, development, and validation of the cranial finite element model. Med Eng Phys 20(8):607-619, 1998. e-Pub 1998. PMID: 9888240.
      42. Chiou RK, Donovan JM, Anderson JC, Matamoros A, Wobig RK, Taylor RJ. Color doppler ultrasound assessment of urethral artery location: potential implication for technique of visual internal urethrotomy. J Urol 159(3):796-799, 1998. e-Pub 1998. PMID: 9474151.
      43. Chiou RK, Anderson JC, Wobig RK, Rosinsky DE, Matamoros A, Chen WS, Taylor RJ. Color doppler ultrasound criteria to diagnose varicoceles: correlation of a new scoring system with physical examination. Urology 50(6):953-956, 1997. e-Pub 1997. PMID: 9426729.
      44. Murayama KM, Grune MT, Matamoros A, Brand RE, Baxter BT. Staple occlusion of the infrarenal aorta: a videoscopic retroperitoneal approach. J Vasc Surg 25(4):786-790, 1997. e-Pub 1997. PMID: 9129642.
      45. Chiou RK, Matamoros A, Anderson JC, Taylor RJ. Changing concepts of urethral stricture management: assessment of urethral stricture disease. Nebr Med J 81(8):282-286, 1996. e-Pub 1996. PMID: 8810228.
      46. Heffron TG, Langnas AN, Matamoros A, Anderson JC, Mack DR, McCashland TM, Dhawan A, Kaufman S, Zetterman RK, Pillen TJ, Sudan D, Jerius J, Donovan JP, Sorrell MF, Vanderhoof JA, Shaw BW. Preoperative estimation in living related donor transplantation: clinical correlation and donor/recipient ratio. Transplant Proc 28(4):2370, 1996. e-Pub 1996. PMID: 8769254.
      47. Stratta RJ, Taylor RJ, Grune MT, Sindhi R, Sudan D, Castaldo P, Cushing KA, Radio SJ, Wisecarver JL, Matamoros A. Experience with protocol biopsies after solitary pancreas transplantation. Transplantation 60(12):1-7, 1995. e-Pub 1995. PMID: 8545870.
      48. Heffron TG, Langnas AN, Fox IJ, Antonson DN, Mack DR, Zetterman R, Donovan J, McCashland T, Matamoros A, Anderson J. Preoperative evaluation of the living related donor in pediatric living related liver transplantation. Transplant Proc 27(1):1180, 1995. e-Pub 1995. PMID: 7878840.
      49. Heffron TG, Anderson JC, Matamoros A, Pillen TJ, Antonson DL, Mack DR, Langnas AN, Fox IJ, Vanderhoof JA, Shaw BW. Preoperative evaluation of donor liver volume in pediatric living related liver transplantation: how accurate is it?. Transplant Proc 26(1):135, 1994. e-Pub 1994. PMID: 8108908.
      50. Matamoros A, Anderson JC, Lieberman RP, McGowan TC, Langnas AN, Jr SB. Diagnosis and radiologic intervention in reduced-size hepatic allografts. Semin Interv Radiol 9(4):290-296, 1992. e-Pub 1992.
      51. Smith CV, Anderson JC, Matamoros A, Rayburn WF. Transvaginal sonography of cervical width and length during pregnancy. J Ultrasound Med 11(9):465-467, 1992. e-Pub 1992. PMID: 1491430.
      52. Matamoros A, Anderson JC, McConnell JR, Bolam DL. Neurosonographic findings in infants treated by extracorporeal membrane oxygenation. J Child Neurol 4(1 suppl):S52-S61, 1989. e-Pub 1989. PMID: 2681379.
      53. Kaplan PA, Anderson JC, Norris MA, Matamoros A. Ultrasonography of post-traumatic soft-tissue lesions. Radiol Clin North Am 27(5):973-982, 1989. e-Pub 1989. PMID: 2672084.
      54. Kottal RA, Vogler JB, Matamoros A, Alexander AH, Cookson JL. Pigmented villonodular synovitis: a report of magnetic resonance imaging in two cases. Radiology 163(2):551-553, 1987. e-Pub 1987. PMID: 3562840.

      Invited Articles

      1. Matamoros A, Lydiatt WB, Lydiatt D, Mahoney E. Pediatric neck masses: computed tomography and magnetic resonance imaging. Appl Radiol 29(5):5-9, 2000. e-Pub 2000.
      2. Matamoros A, Kaplan PA. Sonographic evaluation in the musculoskeletal system. Curr Opin Orthop 3(2):158-163, 1992. e-Pub 1992.
      3. Matamoros A, Kaplan PA. Dynamic ultrasound helps to assess muscles and tendons. Diagn Imaging 11:162-166, 1989. e-Pub 1989.

      Review Articles

      1. Gill IS, Hsu TH, Fox RL, Matamoros A, Miller CD, Leveen RF, Grune MT, Sung GT, Fidler ME. Laparoscopic and percutaneous radiofrequency ablation of the kidney: acute and chronic porcine study. Urology 56(2):197-200, 2000. e-Pub 2000. PMID: 10925077.
      2. Brand RE, Matamoros A. Imaging techniques in the evaluation of adenocarcinoma of the pancreas. Dig Dis 16(4):242-252, 1998. e-Pub 1998. PMID: 9732184.
      3. Tempero M, Brand R, Holdeman K, Matamoros A. New imaging techniques in colorectal cancer. Semin Oncol 22(5):448-471, 1995. e-Pub 1995. PMID: 7570057.
      4. Kaplan PA, Matamoros A, Anderson JC. Sonography of the musculoskeletal system. AJR Am J Roentgenol 155(2):237-245, 1990. e-Pub 1990. PMID: 2115246.

      Other Articles

      1. Elena E, Brian B, Prajnan D, Jeannelyn E, Matamoros A, Jaffer A How do we treat....patients with gastric cancer?. Oncology Times 36(16):11, 2014.

      Abstracts

      1. Estrella J, Higbie V, Le Phat, Brent A, Paradiso F, Hensley M, Sherfield A, Nguyen V, Matamoros A, Lano E, Huey R, Raghav K. Uncovering the tumor microenvironment: Exploring survival and immunotherapy response in cancer of unknown primary, 2025.
      2. Matamoros A. Phase II Trial of Sintilimab in Cancer of Unknown Primary. American Society for Radiation Oncology, 2025. e-Pub 2025.
      3. Ikoma N, Badgwell B, Blum A, Chiang YJ, Das P, Matamoros A, Ajani J, Mansfield P. Phase II clinical trial of preoperative chemoradiation and intraoperative radiation therapy for gastric cancer. Gastric Cancer Congress, 2022. e-Pub 2022.
      4. Mitchell Kyle G, Naruhiko I, David N, Maru Ipen M, Matamoros A, Vaporciyan Ara A, Antonoff Mara B, Mehran Reza J, Rice David C, Roth Jack A, Swicher Stephen G, Boris S, Garrett W, Arlene C, Brian B, Hostetter Wayne L. Patterns of recurrence following trimodality therapy for Siewer type II/III adenocarcinomas of the gastroesophageal junction. Proceedings of the Southern Thoracic Surgical Association's Annual Meeting, 2021. e-Pub 2021.
      5. Kanwal R, Anneleis W, Ryan H, Nishat D, Jignesh M, Matamoros A, Jeannelyn E, Kunal S, Andrey A, Linda C, Cara S, Kevin K, Shannon R, Liu E, Jens R, Scott K, Michael O, Gauri V. Prospective study for comprehensive genomic profiling in cancer of unknown primary: Feasibility, molecular landscape, and clinical utility in current era. Journal of Clinical Oncology 38(4 supplement):834, 2020. e-Pub 2020.
      6. Kaya DM, Nogueras-Gonzalez G, Estrella J, Harada K, Amlashi F, Ghazanfari, Lin Q, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Matamoros A, Sagebiel T, Devine C, Patnana M, Minsky B, Das P, Badgwell B, Ajani J. Potentially curable gastric adenocarcinoma treated without surgery. Eur J Cancer, 2018. e-Pub 2018. PMID: 29859338.
      7. Meera P, Jonathan L, Taggart Melissa W, Anais M, Matamoros A, Keith F, Richard R, Kanwal R. Malignant peritoneal mesothelioma: clinicopathological features, prognostic factors, and survival outcomes, 2018. e-Pub 2018.
      8. Kanwal R, Keith F, Taggart Melissa W, Tim F, Matamoros A, Amire M, Shahab A, Jennifer G, Paul M, Richard R, Cathy E, Michael O. Interplay of grad and stage on survival outcomes in appendiceal adenocarcinoma: Corroboration of the AJCC (8th edition) cancer staging classification. e-Pub 2018.
      9. Mehmet C, Matamoros A, Capadano M, Goertzen T, McCowan T, Brand R, Lynch JC, Tempero M. Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: a phase II trial using intermittent percutaneous Hepatic arterial access. American Society of Clinical Oncology Annual Meeting 90:2404-12, 1999. e-Pub 1999. PMID: 11331319.
      10. Huey, R, Allam J, Xiao, L, Wang X, Brent A, An A, Higbie V, Le, P, Hornstein N, Bust D, Morelli M, Nguyen V, Sherfield A, Matamoros A, Lano E, Portier S, Fung E, Estrella J, Raghav K. Cancer signal origin prediction in cancer of unknown primary syndrome using circulating tumor DNA (ctDNA). European Society for Medical Oncology.

      Book Chapters

      1. Morani, A, Abdelrahman H, Matamoros A, Varadachary, Priya B. Cancer of the Unknown Primary. In: Oncologic Imaging: a Multidisciplinary Approach. 2. Elsevier, 606, 2022.
      2. Guo, C, Bhosale, PR, Rauch, GM, Matamoros Jr, A, Menias, CO, Schmeler, KM, Iyer, RB, Venkatesan, AM. Tumors of the Uterine Corpus. In: Oncologic Imaging: a Multidisciplinary Approach. Elsevier Saunders, 414-437, 2022.
      3. Matamoros A, Schmeler K. Tumors of the uterine corpus. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier Saunders, 423-439, 2012.
      4. Murphy WA, Gladish GW, Gupta S, Kumar A, Matamoros A, Wong FC. Imaging. In: Medical Care of the Cancer Patient. BC Decker Inc, 111-127, 2009.
      5. Anderson JC, Burnett DA, Matamoros A, et al. In vitro gallstone lithotripsy: effect of peripheral calcification on fragmentation and sonographic evaluation of fragment size. In: Shock Wave Lithotripsy 2: Urinary and Biliary Lithotripsy. Plenum Press, 1989.

      Letters to the Editor

      1. Overman M, Eng C, Raghav K, Matamoros A, Taggart M, Foo WC, Fournier K. Challenges of efficacy assessment in pseudomyxoma peritonea. The Oncologist 20: 1-2, 2015.
      2. Chiou K, Matamoros A. Re: Long-term follow-up and selection criteria for penile revascularization in erectile failure. J Urol 162: 1390-1391, 1999.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top